[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"infant-growth\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:infant-growth":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,49,83,115],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100634057","growth-and-health-efficacy-of-novel-infant-formula--a-randomized-trial-100634057",false,"NCT07534735","Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial","Growth, Gut Health, Immune Function, and Sleep Status in Infants and Young Children Fed With Novel Infant Formula : A Randomized Trial","Inclusion Criteria:\n\n* Healthy full-term infants (gestational age 37-42 weeks).\n* Age 12-18 months (inclusive).\n* Weight below the 75th percentile according to the \"Growth Reference Standards for Chinese Children Under 7 Years Old\".\n* Has started or plans to start stage 3 formula feeding before enrollment.\n* Guardian voluntarily signs written informed consent and is able to comply with all study procedures including regular visits, intervention plan, and laboratory tests.\n\nExclusion Criteria:\n\n* Known allergy to milk protein or the study formula.\n* Known allergic constitution or high allergy risk (parent with allergic constitution).\n* Malnutrition assessed by investigator.\n* Chronic infectious disease, metabolic disease, genetic disease, or any other condition affecting feeding or growth and development.\n* History of preterm birth or admission to Neonatal Intensive Care Unit (NICU), excluding phototherapy for jaundice.\n* Severe constipation or diagnosis of other functional gastrointestinal disorders.\n* Cognitive or developmental disorders.\n* Any other condition that, in the investigator's judgment, makes the infant unsuitable for participation.",true,"ALL","12 Months","18 Months",{"count":21,"type":22},120,"ESTIMATED","INTERVENTIONAL",[25],"NA","Randomized, controlled study consisting of three parallel arms to investigate the effects of novel infant formula on growth, gut health, immune function, and sleep status in healthy infants and young children aged 12-18 months.",[28],"Infant Growth",[30,31,28,32,33,34,35],"Human Milk Oligosaccharides","Infant Formula","Gut Health","Immune Function","Sleep","Randomized Controlled Trial","RECRUITING","2026-06-15",{"date":39,"type":40},"2026-06-16","ACTUAL",{"date":42,"type":40},"2026-05-27",{"date":44,"type":22},"2027-01",{"name":46,"class":47},"Biostime (Changsha) Nutrition Foods Limited","INDUSTRY",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":16,"sex":17,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":4,"studyType":23,"phases":61,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":82},"100571349","mothers-and-caregivers-investing-in-children-study-20-100571349","NCT06719102","Mothers and CareGivers Investing in Children Study 2.0","Mothers and CareGivers Investing in Children: MAGIC 2.0","MAGIC 2","Inclusion Criteria:\n\n* A singleton infant 3-9 weeks of age, born ≥37 weeks gestation.\n* The mother and other caregiver must be at least 18 years of age.\n* The infant must live with the mother.\n* Lives within the Austin metropolitan area.\n* English or Spanish speaking.\n* The primary caregiver must identify as the mother.\n\nExclusion Criteria:\n\n* Infant diagnosed with major physical disabilities and\u002For medical condition that affects feeding and growth, and\u002For born \\\u003C37 weeks gestation.\n* Infant experienced NICU stay \\>7 days.\n* Twins, triplets, or other multiples.\n* Mothers and\u002For other caregivers younger than 18 years old.\n* Mothers that do not consent to being video recorded with their baby.\n* Families that do not speak either English or Spanish will be excluded from this study. Families that only speak English or Spanish, or families that speak English or Spanish and another language, will be accepted.\n* Do not plan to remain in Austin area for the next two years.","0 Years","90 Years",{"count":60,"type":22},266,[25],"The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that has been successfully implemented with families as part of the MAGIC 1.0 program trial (IRB#: 2015040017).\n\n* The primary aim is to investigate each intervention's impact on infant BMIZ at 13 months.\n* The investigators will also assess the effect of MAGIC-FEED on caregiver nutrition knowledge and feeding practices, responsive feeding, infant diet, and child self-regulatory abilities and assess how these factors impact child self-regulation of eating and adiposity.\n* Finally, the investigators will determine if the interventions demonstrate the factors necessary to be a successful intervention as determined by the RE-AIM and PRISM frameworks.",[64,65,28],"Childhood Obesity Prevention","Parenting Behavior",[67,68,69,70,71],"Parenting","Infant Feeding","Infant Nutrition","Prevention","Trial","2026-06-08",{"date":74,"type":40},"2026-06-10",{"date":76,"type":40},"2025-02-13",{"date":78,"type":22},"2029-12-31",{"name":80,"class":81},"University of Texas at Austin","OTHER",2,{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":90,"minAge":91,"maxAge":4,"enrollmentInfo":92,"targetDuration":4,"studyType":23,"phases":94,"briefSummary":95,"conditions":96,"keywords":100,"overallStatus":105,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":48},"100577343","breastfeeding-education-support-tool-100577343","NCT06797063","Breastfeeding Education Support Tool","BEST4Baby","Inclusion Criteria:\n\n* at least 18 years of age,\n* pregnant and 20-27 weeks of gestation at study enrollment,\n* singleton pregnancy,\n* no major antepartum complications,\n* living in a research site,\n* planning to deliver in the cluster area,\n* capable of giving informed consent,\n* willing to be visited by a PC and research personnel for up to 12 months post-delivery.\n\nExclusion Criteria:\n\ncomorbidities impacting breastfeeding,\n\n\\- severe psychological illness that could interfere with consent and study participation. Following a live birth, participants will remain eligible to continue in the study unless the mother or infant experiences: illness or clinical complications warranting prolonged hospitalization, stillbirth, low birth weight (\\\u003C 2500 g), congenital abnormality, or neonatal death.","FEMALE","18 Years",{"count":93,"type":22},336,[25],"The proposed project seeks to evaluate the effectiveness and implementation of the Breastfeeding Education Support Tool for Baby (BEST4Baby) intervention, an mHealth-supported community-based peer counselor breastfeeding intervention for mothers in India. Given that rates of optimal infant feeding practices have remained stagnant over the past two decades in India, and that India is the most populous country and icontributes one-fifth of all global live births, this project could have major global health implications if the intervention is found to improve maternal breastfeeding practices and infant clinical outcomes. The project will also provide evidence needed to adopt BEST4Baby nationally and in other low resource communities.",[97,98,28,99],"Breastfeeding, Exclusive","Infant Development","Breast Feeding",[101,102,103,104],"breastfeeding","India","infant feeding","peer counselors","NOT_YET_RECRUITING","2026-05-04",{"date":108,"type":40},"2026-05-05",{"date":110,"type":22},"2026-09-01",{"date":112,"type":22},"2029-09-01",{"name":114,"class":81},"Thomas Jefferson University",{"id":116,"slug":117,"hasResults":11,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":121,"eligibilityCriteria":122,"healthyVolunteers":16,"sex":17,"minAge":123,"maxAge":124,"enrollmentInfo":125,"targetDuration":4,"studyType":23,"phases":127,"briefSummary":128,"conditions":129,"keywords":132,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":144,"completionDateStruct":146,"leadSponsor":148,"locationsCount":48},"100583485","early-avocado-exposure-on-development-and-the-gut-microbiome-in-american-hispanic-infants-100583485","NCT06876935","Early Avocado Exposure on Development and the Gut Microbiome in American Hispanic Infants","Guac & Grow: Early Avocado Exposure on Development and the Gut Microbiome in American Hispanic Infants","Guac & Grow","Inclusion Criteria:\n\n* 4-6-month-old Hispanic\u002FLatine, non-preterm (\\>37 weeks gestation) singleton infants\n* Infants born to mothers 18 years and older while pregnant\n* Parents speak English and\u002For Spanish\n* Families willing to begin feeding infants avocado around 6 months of age or when the infant is ready for solids for a total of 6 months\n* Family history of food or latex allergies will be evaluated as avocado is a latex fruit and can cause allergic responses. If either mom or dad is allergic to avocado, physician clearance for infant participation will be needed.\n* At least one caregiver in the home must have at least an 8th-grade education level\n\nExclusion Criteria:\n\n* Infants with growth, chromosomal, or genetic abnormality, developmental and cognitive impairments, or severe comorbidity that could impact growth and development\n* Infants born with congenital abnormalities or developmental delays\n* Infant birth weights \\\u003C2500 g or \\>4000 g\n* Infants introduced to solid foods prior to 3 months of age\n* Biological mothers with known substance use during pregnancy (alcohol, tobacco, marijuana, or illegal drugs), or who experienced a high-risk pregnancy (e.g., preeclampsia, diabetes-Types 1 and 2 and gestational, HIV, etc.)","3 Months","6 Months",{"count":126,"type":22},150,[25],"The goal of this clinical trial is to learn if daily avocado intake can improve growth and brain and gut health in infants. The main questions it aims to answer are:\n\nDoes daily eating of avocados change which microbes live in the infant's gut? Does daily avocado intake improve infant motor skills and cognitive development?\n\nResearchers will compare avocado intake to standard of care (no or limited avocado intake) to see if regular avocado intake from 6-12 months of life influences gut and brain health.\n\nParticipating mothers\u002Fguardians and their infants will:\n\nParents will provide avocado or no avocado to their infant every day for 6 months starting around 6 months of infant age.\n\nParents will allow study staff to visit participant homes to collect data via surveys and observations and measure infant growth.\n\nParents will swab soiled infant diapers for gut microbe measures. Parents will keep a diary of the infant's avocado consumption and acceptance of the food.\n\nParents will record their infant's dietary intake",[130,131,28],"Gut Microbiome","Neurocognitive Correlates of Eating Habits",[133,134,135,136,137,138,139,140],"avocado","infants","complimentary feeding","growth","development","gut microbiome","neurocognitive","brain health","2025-08-21",{"date":143,"type":40},"2025-08-27",{"date":145,"type":40},"2025-08-05",{"date":147,"type":22},"2027-12-31",{"name":149,"class":81},"Arizona State University"]